NR2C2AP and cancer: Considering the current limited protein level characterization of TRA16 in cancer and paired normal tissues, future studies combining large scale biobank of tissue microarrays and high throughput in situ protein level profiling might provide a more comprehensive pan-cancer view of TRA16 protein expression and enable a comparison between RNA and protein expression.